Both in Pharmaceuticals
Omeros vs LB Pharmaceuticals
Over the past year OMER returned +145.2% and LBRX returned +143.9%; their daily moves had a correlation of 0.15.
OMER +145.2% LBRX +143.9%Growth of $1, one year, split-adjusted
| Metric | OMER | LBRX |
|---|---|---|
| Price | $18.44 | $39.70 |
| Market cap | $1.33B | $1.28B |
| Today | −2.69% | −1.12% |
| 1 month | −0.2% | +6.5% |
| 6 months | +22.4% | +26.3% |
| Year to date | +7.4% | +78.3% |
| 1 year | +140.1% | +153.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | 97.2% | — |
| Net margin | 46.4% | — |
| P/E (TTM) | 10.7× | — |
| Price / sales | 34.7× | — |
| Net cash | $58.7M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | 76.3% | 51.6% |
| Short % of float | 17.8% | 23.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).